Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of TRD303 for postoperative analgesia after abdominal surgery
ChiCTR2500100045Phase 2Not yet recruiting
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of TRD303 in postoperative pain (4 arms), sponsored by Third Xiangya Hospital, Central South University. Primary endpoints: NRS pain intensity score and Proportion of participants taking rescue analgesics. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
TRD303
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2500100045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500100045.